One-year outcomes using ranibizumab for neovascular age-related macular degeneration: results of a prospective and retrospective observational multicentre study.

Hjelmqvist, Lars; Lindberg, Charlotte; Kanulf, Pär; Dahlgren, Henrik; Johansson, Ingrid; Siewert, Annica

doi:10.1155/2011/405724

Public

One-year outcomes using ranibizumab for neovascular age-related macular degeneration: results of a prospective and retrospective observational multicentre study.

Shared by NobleBlocks on Jan 1, 2011 • 12:00 AM UTC

Authors:

Lars Hjelmqvist

Charlotte Lindberg

Pär Kanulf

Abstract

The Swedish Lucentis Quality Registry is a 12-month, open-label, observational, prospective, and retrospective study of ranibizumab administration for wet AMD. Visual acuity (VA) was measured with Snellen or ETDRS chart in 370 patients (66.8% women; age range 46-93 years). In total, a mean of 4.7 ± ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!